O'Brien P Q, Park J H, Klinger H. "Method for the Synthesis of 6-Methyloctahydropyrrolo[3,4-b][1,4]oxazine" [P]. US Patent, US 11570954 B2, 2016-10-17.
Sørensen M, Rossi M, Nielsen H. "A Process for Preparing High-Purity 6-Methyloctahydropyrrolo[3,4-b][1,4]oxazine" [P]. European Patent, EP 3037486 A1, 2019-04-17.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2018, 345, (12), 5811-5830.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2023, 1753, 1092-1121.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 6-Methyloctahydropyrrolo[3,4-b][1,4]oxazine Using HRMS and NMR". Anal. Chim. Acta, 2016, 734, (10), 9759-9783.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2016, 1731, 5111-5122.